Xeltis Overview
Founded
2006
Status
Private
Employees
30
Latest Deal Type
Series D
Latest Deal Amount
$11.7M
Investors
6
Xeltis General Information
Description
Operator of a clinical-stage medical device company pioneering a restorative approach in cardiovascular therapy. The company's devices enable the patient's own body to naturally restore a new blood vessel or heart valve through a therapeutic approach called Endogenous Tissue Restoration (ETR).
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
- Seefeldstrasse 69
- 8008 Zurich
- Switzerland
+41 044 000 00 00
Xeltis Timeline
Xeltis Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series D) | 05-Sep-2019 | $11.7M | 0000 | Completed | Clinical Trials - General | |
| 3. Later Stage VC (Series C) | 15-Nov-2017 | 000.00 | 000.00 | Completed | Clinical Trials - General | |
| 2. Later Stage VC (Series B) | 24-Sep-2015 | $33.7M | $33.7M | Completed | Clinical Trials - General | |
| 1. Early Stage VC | Completed | Startup |
Xeltis Competitors (17)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| QT Vascular | Corporation | Singapore, Singapore | 000.00 | 000000000 | 000.00 | |
| 0000000 0000000000 | Venture Capital-Backed | Kirkland, WA | 00 | 00000 | 00000000000 | 00000 |
| 000 | Formerly PE-Backed | Leesburg, VA | 000 | 00000 | 000000&0 | 00000 |
| 000000000 | Corporate Backed or Acquired | Framingham, MA | 000 | 00000 | 000000&0 | 00000 |
| 000000 | Angel-Backed | Eagan, MN | 0000 | 0000000000 | 0000 |
Xeltis Executive Team (30)
9 Former Executives
Xeltis Board Members (11)
| Name | Representing | Role | Since |
|---|---|---|---|
| Christian Wenger Ph.D | Self | Board Member | 000 0000 |
| Clemens Van Blitterswijk Ph.D | Life Sciences Partners | Board Member | 000 0000 |
| Eliane Schutte | Xeltis | Chief Executive Officer & Board Member | 000 0000 |
| Karen Wagner | Ysios Capital | Board Member | 000 0000 |
| Michael Colson | Self | Chairman of the Scientific Advisory Board | 000 0000 |
5 Former Board Members
Xeltis Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Ysios Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Kurma Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Life Sciences Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
| StartAngels Network | Angel Group | Minority | 000 0000 | 000000 0 | |
| VI Partners | Venture Capital | Minority | 000 0000 | 000000 0 |
Ready to get started?
Request a free trial